新修订的《药品不良反应报告和监测管理办法》七月一日施行
摘要
2011年5月4日,陈竺部长以卫生部令第81号颁布《药品不良反应报告和监测管理办法》(以下简称“新《办法》”)正式颁布,并将于2011年7月1日起施行。新《办法》是我国开展药品不良反应监测工作的重要法律基础。也是药监部门蛋彻落实科学发展观和医疗卫生体制改革要求。
出处
《中国医药导刊》
2011年第6期I0001-I0001,共1页
Chinese Journal of Medicinal Guide
参考文献10
-
1霍勇.急性冠脉综合征危险分层方法的评价[J].心血管病学进展,2006,27(3):252-256. 被引量:14
-
2Simona Kirbi?,Ur?ka D. Breskvar,Mi?o ?abovi?,Igor Zupan,Andreja Sinkovi?.Inflammation markers in patients with coronary artery disease – comparison of intracoronary and systemic levels[J]. Wiener klinische Wochenschrift . 2010 (2)
-
3Kyeong Ho Yun,Myung Ho Jeong,Seok Kyu Oh,Sang Jae Rhee,Eun Mi Park,Eun Mi Lee,Nam Jin Yoo,Nam-Ho Kim,Young Keun Ahn,Jin-Won Jeong.Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome[J]. Heart and Vessels . 2009 (3)
-
4Lim R,Starmer G.ACS scores: risky business?. Heart . 2009
-
5Brieger D,Fox KA,Fitzgerald G, et al.Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart . 2009
-
6Monteiro CM,Pinheiro LF,Izar MC, et al.Highly sensitive C-reactive protein and male gender are independently related to the severity of coronary disease in patients with metabolic syndrome and an acute coronary event. Brazilian Journal of Medical and Biological Research . 2010
-
7Pitsavos C,Panagiotakos D,Zombolos S, et al.Greek Study of Acute Coronary Syndromes (GREECS) Investigators Group. Systolic blood pressure on admission predicts in-hospital mortality among patients presenting with acute coronary syndromes: the Greek study of acute coronary syndromes. J Clin Hypertens (Gree nwich) . 2008
-
8von Korn H,Graefe V,Ohlow MA, et al.Acute coronary syndrome without significant stenosis on angiography: characteristics and prognosis. Texas Heart Institute Journal . 2008
-
9FS Apple,RL Jesse,LK Newby,AH Wu,RH Christenson.National Academy of Clinical Biochemistry: IFCC Committee for Standardization of Markers of Cardiac Damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation . 2007
-
10Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelin. Journal of the American College of Cardiology . 2002
二级参考文献21
-
1Libby P.Current concepts of the pathogenesis of the acutecoronary syndromes[J].Circulation,2001,104:365-372.
-
2Boersma E,Pieper KS,Steyerberg EW,et al.Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation:results from an international trial of 9 461 patients[J].Circulation,2000,101:2557-2567.
-
3Sanonitto S,Ardissino D,Granger CB,et al.Prognistic value of the admission electrocardiogram in acute coronary syndrome[J].JAMA,1999,281:707-713.
-
4Antman EM,Cohen M,Bernink PJLM,et al.The TIMI risk score for unstable angina/non ST-elevation MI:a method for prognostication and therapeutic decision making[J].JAMA,2000,284:835-842.
-
5Cohen M,Stinnett SS,Weatherly BD,et al.Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy[J].Am Heart J,2000,139:962-970
-
6Apple FS,Falahati A,Paulsen PR,et al.Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I[J].Clin Chem,1997,43:2047-2051.
-
7Ohman EM,Armstrong PW,Christenson RH,et al.For the GUSTO ⅡA Investigators.Cardiac troponin T levels for risk stratification in acute myocardial ischemia[J].N Engl J Med,1996,335:1333-1341.
-
8Antman EM,Tanasijevic MJ,Thompson B,et al.Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes[J].N Engl J Med,1996,335:1342-1349.
-
9Hamm CW,Heeschen C,Goldmann B,et al.For the c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels[J].N Engl J Med,1999,340:1623-1629.
-
10PRISM Study investigators.Tropnin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban[J].Lancet,1999,354:1757-1762.
共引文献13
-
1刘彦茹,焦志勤,杨东辉,辛凤芝.ST段抬高型急性心肌梗死院前溶栓对比分析[J].中国心血管病研究,2006,4(12):956-958. 被引量:6
-
2王挹青,陈伟斌.有关急性冠脉综合征治疗策略的几个问题[J].临床急诊杂志,2007,8(1):3-5. 被引量:1
-
3孙春沿.急性冠状动脉综合征与血栓素A_2含量相关性[J].中国慢性病预防与控制,2007,15(6):571-572. 被引量:1
-
4孙春沿.不稳定型心绞痛与血栓素A_2含量的相关性分析[J].江西医药,2008,43(4):313-315. 被引量:1
-
5吴桦,许鹏程,王丽娟.急性心肌梗死早期静脉溶栓治疗的价值[J].实用全科医学,2008,6(6):597-598. 被引量:2
-
6吴桦.急性心肌梗死院前溶栓与院内溶栓的对比分析[J].中国医药指南(学术版),2008,6(5):50-51. 被引量:2
-
7王翠英,李敏,李虹伟.BNP水平与急性冠脉综合征远期预后相关性分析[J].医学临床研究,2011,28(1):4-7. 被引量:3
-
8王嘉莉,柯元南.急性冠脉综合征的危险因素及冠脉造影的相关表现[J].中国医药导刊,2011,13(6):923-924.
-
9曹志宇.急性ST段抬高型心肌梗死院前与院内溶栓对比分析[J].中国实用医药,2012,7(14):146-147. 被引量:1
-
10孙兴国,庞军.非ST段抬高急性冠状动脉综合征危险分层[J].心电与循环,2013,32(5):355-361. 被引量:1
-
1国家食品药品监管局修订发布《药品不良反应报告和监测管理办法》[J].中国医药导报,2011,8(17):1-1. 被引量:2
-
2《药品不良反应报告和监测管理办法》修订发布[J].中国药房,2011,22(25):2400-2400.
-
3处方的开具[J].广东牙病防治,2009,17(4):160-160.
-
4北京市药品监督管理局 北京市卫生局关于发布《北京市药品不良反应报告和监测管理办法实施细则》的公告[J].北京市人民政府公报,2012,0(10):53-64.
-
5《国家基本药物目录(基层医疗卫生机构配备使用部分)》(2009版)公布[J].中国药房,2009,20(25):1953-1953.
-
6药品不良反应报告和监测管理办法[J].中国药物经济学,2011(5):68-75. 被引量:32
-
7国家食品药品监督管理局要求做好贯彻落实《药品不良反应报告和监测管理办法》工作[J].中国药事,2011,25(7):709-709. 被引量:1
-
8国家食品药品监督管理局要求做好贯彻落实《药品不良反应报告和监测管理办法》工作[J].中国药房,2011,22(29):2722-2722. 被引量:3
-
9抗菌药物临床应用管理办法[J].中国药物评价,2012,29(2):109-112. 被引量:4
-
102012年版《国家基本药物目录》发布[J].上海医药,2013,34(7):46-46.